Diclofenac/lidocaine - Yung Shin

Drug Profile

Diclofenac/lidocaine - Yung Shin

Alternative Names: Topical VDO; VDO

Latest Information Update: 01 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Yung Shin Pharmaceutical
  • Class
  • Mechanism of Action Cyclophilin inhibitors; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Herpes labialis

Most Recent Events

  • 31 Mar 2017 No recent reports of development identified - Phase-II for Herpes labialis in Taiwan (Topical)
  • 01 Jul 2014 Phase-II clinical trials in Herpes labialis in Taiwan (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top